Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
DOW CHEMICAL CO/THE

Muhlenkamp & Co DOW CHEMICAL CO/THE transactions over time

DOW-OLD

DOW CHEMICAL CO/THE historical holders

total: 3

Transactions details

Total transactions:
3
New positions:
1
Sold out:
1
Reduced:
1
Held since:
2017 Q1
Held for:
2 quarters
Latest activity:
2017 Q3
Ronald Muhlenkamp has been an institutional investor in DOW CHEMICAL CO/THE (DOW-OLD) since 2017 Q1. According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any shares. The fund/company first acquired DOW-OLD in 2017 Q1, initially purchasing 118,055 shares. Since the initial investment, Muhlenkamp & Co has made 2 more transactions in this position.

When did Ronald Muhlenkamp exit their DOW-OLD position?

Ronald Muhlenkamp no longer holds DOW CHEMICAL CO/THE (DOW-OLD). They sold off their entire position in 2017 Q3, closing out an investment that began in 2017 Q1.

When did Ronald Muhlenkamp first invest in DOW-OLD?

Ronald Muhlenkamp first invested in DOW CHEMICAL CO/THE (DOW-OLD) in 2017 Q1 at the reported quarter-end price of $63.54 per share, acquiring 118,055 shares in their initial purchase.

What is Ronald Muhlenkamp's average cost basis for DOW-OLD?

Based on historical transaction data, Ronald Muhlenkamp's estimated cost basis for DOW CHEMICAL CO/THE (DOW-OLD) is approximately $63.54 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$63.54
Weighted AVG sell price:
$63.07

DOW-OLD transactions history by Muhlenkamp & Co

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2017 Q3
0.00%
$63.07
-100% (-117,895)
2017 Q2
2.44%
$63.07
-0.14% (-160)
2017 Q1
2.43%
$63.54
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.